Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Phillip Frost


Dr. Phillip Frost is the Founder at OPKO Health and serves as Chairman, Chief Executive Officer, Board Member and. He has been the CEO and Chairman of the Company since March 2007. Dr. Frost served as a director of Teva Pharmaceutical Industries, Limited, or Teva (NYSE:TEVA) from January 2006 until February 2015 and had previously served as Chairman of the Board of Teva from March 2010 until December 2014 and as Vice Chairman from January 2006 until March 2010. Dr. Frost had served as Chairman of the Board of Directors and Chief Executive Officer of IVAX Corporation from 1987 until its acquisition by Teva in January 2006. He was Chairman of the Department of Dermatology at Mt. Sinai Medical Center of Greater Miami, Miami Beach, Florida from 1972 to 1986. Dr. Frost was Chairman of the Board of Directors of Key Pharmaceuticals, Inc. from 1972 until the acquisition of Key Pharmaceuticals by Schering Plough Corporation in 1986. Dr. Frost was named Chairman of the Board of Ladenburg Thalmann Financial Services Inc. (NYSE MKT:LTS), an investment banking, asset management, and securities brokerage firm providing services through its principal operating subsidiary, Ladenburg Thalmann & Co. Inc., in July 2006 and has been a director of Ladenburg Thalmann from 2001 until 2002 and again since 2004. He serves as a member of the Board of Trustees of the University of Miami, the Skolkovo Foundation Scientific Advisory Council in Russia, the Shanghai Institute for Advanced Immunochemical Studies in China, and The Florida Council of 100 and as a Trustee of each of the Miami Jewish Home for the Aged and the Mount Sinai Medical Center. Dr. Frost is also a director of Castle Brands (NYSE MKT:ROX), a developer and marketer of premium brand spirits, Cocrystal Pharma, Inc. (OTCBB: COCP), formerly Biozone Pharmaceuticals, Inc., a publicly traded biotechnology company developing new treatments for viral diseases, and Sevion Therapeutics, Inc. (OTCBB:SVON), a clinical stage company which discovers and develops next-generation biologics for the treatment of cancer and immunological diseases. Dr. Frost previously served as a director for Continucare Corporation, TransEnterix, Inc., SafeStitch Medical Inc. prior to its merger with TransEnterix, Inc. and PROLOR Biotech, Inc. prior to its acquisition by the Company in August 2013, as Governor and Co-Vice-Chairman of the American Stock Exchange (now NYSE MKT), and as a member of the Board of Trustees of the Scripps Research Institute until November 2012. Dr. Phillip Frost serves as Advisory Committee Member at MBF Healthcare Partners. He serves on the Board of Regents of the Smithsonian Institution, is a member of the Board of Trustees of the University of Miami, Governor of Tel Aviv University, Chairman of Temple Emanu-El, and is a Trustee of each of the Scripps Research Institutes, the Miami Jewish Home for the Aged, and Mount Sinai Medical Center. He is an Angel Investor.

Investor Status
Actively Seeking New Investments
Primary Investor Type
Angel (individual)
Primary Office
  • Miami Beach, FL
  • United States

Phillip Frost Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
00000 000000000000 02-Aug-2017 00000 00000 0000 Biotechnology Generating Revenue 0000000 00000 00
To view this investor’s complete investment and acquisition history, request access »
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Phillip Frost’s full profile, request a free trial.

Phillip Frost Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
00000 000000000000 000000000 00000000 Completed
To view this investor’s complete exits history, request access »

Phillip Frost Team (1)

Name Title Deals Funds Boards Office Contact
Phillip Frost MD Angel Investor 00 0 Miami Beach, FL